Clinical trials
Recruiting Burkitt Lymphoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
114 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 2 |
| 2011 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 5 |
| 2019 | 6 |
| 2020 | 5 |
| 2021 | 5 |
| 2022 | 9 |
| 2023 | 12 |
| 2024 | 22 |
| 2025 | 29 |
| 2026 | 12 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 114 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 8 |
| Medical College of Wisconsin | 5 |
| Institute of Hematology & Blood Diseases Hospital, China | 4 |
| M.D. Anderson Cancer Center | 4 |
| The First Affiliated Hospital of Soochow University | 4 |
| Beijing GoBroad Hospital | 3 |
| AstraZeneca | 2 |
| Children's Hospital Medical Center, Cincinnati | 2 |
| City of Hope Medical Center | 2 |
| Juventas Cell Therapy Ltd. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Burkitt Lymphoma | 114 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 28 |
| Lymphoma, Large B-Cell, Diffuse | 21 |
| Lymphoma, B-Cell | 18 |
| Lymphoma, Follicular | 18 |
| Lymphoma, Non-Hodgkin | 16 |
| Recurrence | 16 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 14 |
| Lymphoma, Mantle-Cell | 14 |
| Lymphoma, B-Cell, Marginal Zone | 13 |
Trials
Showing 51 to 75 of 114. Each trial links to its page on Pharma Observatory.
14 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.